Effectiveness of LSVT BIG on patients with Parkinson’s Disease for the improvement of functional mobility

No Thumbnail Available
DeMeo, Alexandria
O'Meara, Brooke
Burrington, Lukas
Grewe, Tessa
Jewell, Noelle
Issue Date
Critically Appraised Topic Paper
Research Projects
Organizational Units
Journal Issue
Alternative Title
ABSTRACT BACKGROUND: Parkinson’s disorder (PD) is a neurodegenerative disorder that affects the central nervous system, primarily affecting the production of dopamine, which leads to progressive symptoms, including difficulties with movement. Individuals with PD may feel their movements and posture are “normal” and may lack awareness of impaired motor movements. Those with PD may experience impaired balance and coordination, shuffled gait, bradykinesia, muscle stiffness, loss of higher cognitive function, sensory changes, and tremors. The impaired motor movements individuals with PD experience impact occupational participation and performance in both large and small daily activities. Occupational therapists can assist with improving these activities such as dressing including buttoning a shirt or tying their shoes, sitting and standing from a chair, maintaining balance, and helping patients safely navigate their environment while engaging in meaningful activities. AIM: This critically appraised topic (CAT) aims to determine the effectiveness of the LSVT BIG program for improving functional mobility in patients with Parkinson’s Disease (PD). METHODS: Literature search analysis led to the inclusion of Level 1A, 1B, 2B, and 3B studies that focus on this study's aim. Studies were analyzed to include literature from the past ten years. The studies included the following outline criteria: patients with PD participating in LSVT BIG to improve functional mobility. Seven articles met the established standards. RESULTS: Level 1A, 1B, 2B, and 3B research completed on LSVT BIG has revealed moderated evidence regarding its effectiveness in increasing functional mobility in patients diagnosed with PD. Further research needs to be conducted with larger sample sizes to increase generalizability and assess long-term outcomes, and more systematic reviews and RCTs should be completed to increase the strength of evidence for the use of LSVT with PD patients.
Creighton University
Copyright is retained by the Author. A non-exclusive distribution right is granted to Creighton University
PubMed ID